Fund Houses Recommendations: ONGC, Apollo Hospitals, Voltas, Adani Ports, Pidilite
Ahmedabad, 14 August
MS on ONGC: Maintain Overweight on Company, target price at Rs 206/sh (Positive)
JP Morgan on Apollo Hospitals: Maintain Overweight on Company, target price at Rs 5950/sh (Positive)
Macquarie on Apollo Hospitals: Maintain Buy on Company, target price at Rs 5940/sh (Positive)
CLSA on Lemon Tree: Maintain Buy on Company, target price at Rs 117/sh (Positive)
CLSA on Campus: Maintain Buy on Company, target price at Rs 365/sh (Positive)
HSBC on Voltas: Maintain Buy on Company, target price at Rs 1000/sh (Positive)
CLSA on Voltas: Maintain Buy on Company, target price at Rs 1000/sh (Positive)
Kotak on JSPL: Maintain Buy on Company, raise target price at Rs 815/sh (Positive)
Nomura on Hero Motocorp: Maintain Neutral on Company, raise target price at Rs 3446/sh (Positive)
Jefferies on ABB: Maintain Buy on Company, raise target price at Rs 5260/sh (Positive)
CLSA on Adani Ports: Maintain Buy on Company, target price at Rs 878/sh (Neutral)
Jefferies on Adani Ports: Maintain Buy on Company, target price at Rs 890/sh (Neutral)
MS on JSPL: Maintain Underweight on Company, target price at Rs 460/sh (Neutral)
JP Morgan on Info Edge: Maintain Neutral on Company, target price at Rs 4600/sh (Neutral)
Kotak on Voltas: Maintain Sell on Company, target price at Rs 750/sh (Neutral)
Jefferies on Voltas: Maintain Buy on Company, target price at Rs 950/sh (Neutral)
MS on Voltas: Maintain Underweight on Company, target price at Rs 735/sh (Neutral)
MS on Crompton: Maintain Equal weight on Company, target price at Rs 277/sh (Neutral)
Citi on Pidilite: Maintain Reduce on Company, target price at Rs 1780/sh (Neutral)
Macquarie on Pidilite: Maintain Underperform on Company, target price at Rs 2100/sh (Neutral)
BofA on Nykaa: Downgrade to Neutral on Company, target price at Rs 160/sh (Negative)
CLSA on JSPL: Downgrade to Underperform on Company, target price at Rs 720/sh (Negative)
MS on JSPL: Maintain Underweight on Company, target price at Rs 460/sh (Negative)
CLSA on Astral: Downgrade to Sell on Company, target price at Rs 1720/sh (Negative)
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)